Search research articles
Contact Us
Filters
Showing results (111-120 of 124) with videos related to
Page
of 13
Sort By:
Journal of the American Chemical Society
|
December 26, 2024
Synergistic Ultrasound-Activable Artificial Enzyme and Precision Gene Therapy to Suppress Redox Homeostasis and Malignant Phenotypes for Controllably Combating Hepatocellular Carcinoma
Yinghao Lyu, Qian Li, Sinan Xie, et al.
Plos One
|
March 13, 2010
Discovery of novel microRNAs in female reproductive tract using next generation sequencing
Chad J Creighton, Ashley L Benham, Huifeng Zhu, et al.
Gut
|
March 31, 2021
Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting <i>ARID1A</i> deficiency
Xiaochuan Dong, Shumei Song, Yuan Li, et al.
Molecular Cancer
|
March 26, 2021
Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
Yan Xu, Yuan Li, Jiankang Jin, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 24, 2021
Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma
Shumei Song, Yan Xu, Longfei Huo, et al.
Molecular Cancer
|
October 12, 2019
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
Yan Xu, Yuan Li, Jiankang Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2018
YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer
Fan Li, Yan Xu, Bovey Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 22, 2022
GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
Yuan Li, Yibo Fan, Jinbang Xu, et al.
Gut
|
January 25, 2021
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma
Shumei Song, Qiongrong Chen, Yuan Li, et al.
British Journal of Cancer
|
November 15, 2017
Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors
Jaffer A Ajani, Jeannelyn S Estrella, Qiongrong Chen, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 124) with videos related to
Sort By:
Page
of 13
Journal of the American Chemical Society
|
December 26, 2024
Synergistic Ultrasound-Activable Artificial Enzyme and Precision Gene Therapy to Suppress Redox Homeostasis and Malignant Phenotypes for Controllably Combating Hepatocellular Carcinoma
Yinghao Lyu, Qian Li, Sinan Xie, et al.
Plos One
|
March 13, 2010
Discovery of novel microRNAs in female reproductive tract using next generation sequencing
Chad J Creighton, Ashley L Benham, Huifeng Zhu, et al.
Gut
|
March 31, 2021
Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting <i>ARID1A</i> deficiency
Xiaochuan Dong, Shumei Song, Yuan Li, et al.
Molecular Cancer
|
March 26, 2021
Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
Yan Xu, Yuan Li, Jiankang Jin, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 24, 2021
Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma
Shumei Song, Yan Xu, Longfei Huo, et al.
Molecular Cancer
|
October 12, 2019
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
Yan Xu, Yuan Li, Jiankang Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2018
YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer
Fan Li, Yan Xu, Bovey Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 22, 2022
GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
Yuan Li, Yibo Fan, Jinbang Xu, et al.
Gut
|
January 25, 2021
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma
Shumei Song, Qiongrong Chen, Yuan Li, et al.
British Journal of Cancer
|
November 15, 2017
Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors
Jaffer A Ajani, Jeannelyn S Estrella, Qiongrong Chen, et al.
Page
of 13